Vertex Pharmaceuticals Incorporated (ETR:VX1)

Vertex Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 26, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	106,813	97,968	100,171	94,857	69,361	49,095
Market Cap Growth	-5.01%	-2.20%	5.60%	36.76%	41.28%	-2.28%
Enterprise Value	98,109	89,302	91,039	83,201	60,990	43,745
Last Close Price	417.50	391.35	387.65	371.20	270.10	197.14
PE Ratio	31.72	29.10	-	28.97	22.31	23.84
PS Ratio	10.45	9.58	9.41	10.62	8.30	7.37
PB Ratio	6.72	6.16	6.32	5.96	5.33	5.53
P/TBV Ratio	7.31	6.71	7.15	6.70	6.07	6.42
P/FCF Ratio	39.27	36.02	-	31.42	18.89	23.18
P/OCF Ratio	34.54	31.68	-	29.64	17.95	21.12
EV/Sales Ratio	9.66	8.74	8.55	9.32	7.30	6.57
EV/EBITDA Ratio	22.68	21.55	20.59	20.54	14.40	12.38
EV/EBIT Ratio	24.73	22.37	21.45	21.35	14.89	12.78
EV/FCF Ratio	36.07	32.83	-	27.56	16.61	20.66
Debt / Equity Ratio	0.11	0.11	0.11	0.05	0.07	0.10
Debt / EBITDA Ratio	0.40	0.40	0.37	0.18	0.20	0.24
Debt / FCF Ratio	0.64	0.64	-	0.24	0.23	0.40
Net Debt / Equity Ratio	-0.55	-0.55	-0.58	-0.73	-0.72	-0.65
Net Debt / EBITDA Ratio	-2.11	-2.11	-2.07	-2.88	-2.21	-1.63
Net Debt / FCF Ratio	-3.22	-3.22	11.99	-3.87	-2.54	-2.72
Asset Turnover	0.50	0.50	0.49	0.48	0.57	0.60
Inventory Turnover	3.85	3.85	5.31	7.38	8.87	8.97
Quick Ratio	2.24	2.24	2.17	3.60	4.46	4.04
Current Ratio	2.90	2.90	2.69	3.99	4.83	4.46
Return on Equity (ROE)	22.54%	22.54%	-3.15%	22.99%	27.67%	24.93%
Return on Assets (ROA)	12.16%	12.16%	12.14%	13.17%	17.33%	19.32%
Return on Invested Capital (ROIC)	29.60%	30.54%	-98.60%	63.54%	90.72%	102.53%
Return on Capital Employed (ROCE)	21.50%	21.50%	23.20%	22.50%	28.40%	34.50%
Earnings Yield	3.15%	3.44%	-0.52%	3.45%	4.48%	4.20%
FCF Yield	2.55%	2.78%	-0.76%	3.18%	5.29%	4.31%
Buyback Yield / Dilution	-0.04%	-0.04%	1.00%	-0.54%	0.31%	1.33%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.